Comparison of survival analysis of different clinicopathological factors affecting OS in 376 patients with NECC in the training cohort.

Abstract

A, Race; B, Tumor size; C, Lymph node metastasis; D, Distant metastasis; E, Stage; F, Chemotherapy. (TIF)</p